PUBLICATION

Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.


PUBLICATION ARCHIVES

SEARCH THE ARCHIVES

Issue #87, March 2009

Fraud Count in Amended Master Trasylol Complaint May Proceed

A federal judge has ruled that fraud allegations contained in a master complaint filed by plaintiffs in the Trasylol MDL should not be dismissed


Pathologist Who Lost $12 Million Gambling on Requip Can't Prove Causation

A Texas judge has awarded summary judgment to GlaxoSmithKline and ordered that a plaintiff whose gambling habit was allegedly caused by Requip


N.J. Judge Cites <i>Levine</i> in Decision Remanding Elidel Action

A plaintiff's state law claims for injuries he suffered after taking Elidel do not require resolution of issues premised on the application of federal law


No Certainty in Ephedra-Stroke Link Prior to 2002, N.Y. Judge Rules

Genuine issues of material fact exist as to whether sufficient scientific medical evidence was available prior to 2002 that would have indicated


Judge: Fosamax Expert Must be Deposed in Australia at Plaintiffs' Expense

An expert that plaintiffs in the Fosamax litigation consider "unique and critical to the case" must be deposed in Australia


U.S. Supreme Court Rejects Wyeth Preemption Argument

The U.S. Supreme Court has issued its long-awaited opinion in <i>Wyeth v. Levine</i>, ruling that state law failure-to-warn claims are not preempted


Issue #86, February 2009

Forum Motion Denied, Docket Created for 2nd Round of Oxycontin Cases

A state court judge in New York has denied a defense motion to dismiss hundreds of Oxycontin cases brought by out-of-state plaintiffs


Neurontin No-Injury Claims Dismissed as Judge Decertifies Class

A class action for off-label promotion of Neurontin has been decertified after the drug's manufacturer was awarded partial summary judgment


Court Affirms Effexor Defense Verdict, Exclusion of Warnings Evidence

A federal appeals court has upheld a verdict for Wyeth Inc. in an Effexor suicide case, determining that the trial judge did not


Magistrate Recommends Stay of Action Pending JPML Decision

A federal magistrate judge has recommended that a Trasylol suit not be remanded to state court and be stayed pending a decision by the JPML as to whether


Past Issues:


VERDICTRACK

The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.

  • DEFENDANT
  • DISEASE / INJURY
  • PRODUCT
  • PUBLICATION
  • STATE
  • SEARCH BY EXPERT